BioXcel Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ARMISTICE CAPITAL, LLC | 02/14/2025 | 4.32 M | $1.61 M | 100.00% | 10.18% |
UBS GROUP AG | 02/14/2025 | 1.28 M | $477,558 | 9,552.96% | 3.01% |
VANGUARD GROUP INC | 02/11/2025 | 1.19 M | $444,112 | -1.16% | 2.80% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 311,965 | $116,667 | 4.67% | 0.74% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 104,972 | $39,249 | -18.48% | 0.25% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 77,900 | $29,127 | -40.02% | 0.18% |
SQUAREPOINT OPS LLC | 02/14/2025 | 72,046 | $26,938 | 203.86% | 0.17% |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 02/14/2025 | 38,050 | $14,000 | 0.00% | 0.09% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 34,531 | $12,911 | 0.95% | 0.08% |
HRT FINANCIAL LP | 02/14/2025 | 25,505 | $9,000 | 100.00% | 0.06% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 380,608 | $142,309 | 5.00% | 0.06% |
JANE STREET GROUP, LLC | 02/14/2025 | 23,343 | $8,728 | -52.67% | 0.06% |
GROUP ONE TRADING, L.P. | 02/14/2025 | 18,116 | $6,774 | -39.94% | 0.04% |
TWO SIGMA SECURITIES, LLC | 02/14/2025 | 17,316 | $6,474 | 100.00% | 0.04% |
POINT72 ASIA (SINGAPORE) PTE. LTD. | 02/14/2025 | 15,939 | $5,960 | 4.96% | 0.04% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 199,010 | $74,410 | 7.54% | 0.03% |
ENGINEERS GATE MANAGER LP | 02/14/2025 | 11,985 | $4,481 | 100.00% | 0.03% |
ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 8,500 | $5,185 | 0.00% | 0.02% |
STATE STREET CORP | 02/14/2025 | 77,149 | $28,846 | 0.00% | 0.01% |
FEDERATED HERMES, INC. | 02/13/2025 | 4,819 | $1,802 | 0.00% | 0.01% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 4,262 | $1,594 | 100.00% | 0.01% |
ARETE WEALTH ADVISORS, LLC | 02/12/2025 | 40,500 | $15,000 | 0.00% | 0.01% |
DIVERSIFY WEALTH MANAGEMENT, LLC | 01/16/2025 | 40,000 | $15,092 | 0.00% | 0.01% |
HENNION & WALSH ASSET MANAGEMENT, INC. | 01/15/2025 | 39,368 | $14,720 | -1.82% | 0.01% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 2,321 | $868 | -94.77% | 0.01% |
ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 02/07/2025 | 1,653 | $618 | -72.58% | 0.00% |
JPMORGAN CHASE & CO | 02/12/2025 | 1,328 | $496 | 77.30% | 0.00% |
VIRTU FINANCIAL LLC | 02/11/2025 | 16,983 | $6,000 | 100.00% | 0.00% |
02/06/2025 | 12,701 | $4,749 | 100.00% | 0.00% | |
DAVENPORT & CO LLC | 01/24/2025 | 11,810 | $4,416 | -29.93% | 0.00% |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 02/10/2025 | 11,800 | $4,412 | -0.84% | 0.00% |
SEACREST WEALTH MANAGEMENT, LLC | 01/14/2025 | 11,150 | $4,169 | -9.72% | 0.00% |
NEWEDGE ADVISORS, LLC | 02/13/2025 | 500 | $187 | 0.00% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 259 | $97 | -97.65% | 0.00% |
WASHINGTON TRUST ADVISORS, INC. | 02/06/2025 | 2,572 | $962 | 0.00% | 0.00% |
FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 02/14/2025 | 113 | $42 | 0.00% | 0.00% |
PARKSIDE FINANCIAL BANK & TRUST | 02/05/2025 | 1,800 | $674 | 0.00% | 0.00% |
NATIONAL BANK OF CANADA /FI/ | 02/12/2025 | 1,020 | $381 | -57.05% | 0.00% |
POINT72 (DIFC) LTD | 02/14/2025 | 35 | $13 | 12.90% | 0.00% |
US BANCORP \DE\ | 02/05/2025 | 33 | $12 | -99.82% | 0.00% |
FARTHER FINANCE ADVISORS, LLC | 02/10/2025 | 95 | $36 | 100.00% | 0.00% |
TRUIST FINANCIAL CORP | 01/31/2025 | 0 | $0 | -100.00% | 0.00% |
COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 0 | $0 | -100.00% | 0.00% |
CITIGROUP INC | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
TOTH FINANCIAL ADVISORY CORP | 01/21/2025 | 0 | $0 | -100.00% | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
SIMPLEX TRADING, LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
ALLSQUARE WEALTH MANAGEMENT LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
APOLLON WEALTH MANAGEMENT, LLC | 01/28/2025 | 0 | $0 | -100.00% | 0.00% |
XTX TOPCO LTD | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
BioXcel Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 61 institutional investors and hedge funds held shares of BioXcel Therapeutics, Inc.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 4.32 M
UBS Group AG: 1.28 M
VANGUARD GROUP INC: 1.19 M
BlackRock Funding, Inc. /DE: 380,608
GEODE CAPITAL MANAGEMENT, LLC: 311,965
WELLS FARGO & COMPANY/MN: 199,010
1.26% of BioXcel Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 9.00 M shares in the last 24 months. This purchase volume represents approximately $5.13 M in transactions.